Natera Inc (NTRA)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Natera Inc (NTRA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011280
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes translocation testing, aneuploidy screening, and single gene testing. Natera offers constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company’s algorithms and bioinformatics in order to validate and launch tests. The company also undertakes clinical trial of several genetic materials. Natera is headquartered in San Carlos, California, the US.

Natera Inc (NTRA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Natera Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Natera Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Natera Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Natera Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Natera Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Natera Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Natera Raises USD55.5 Million in Venture Financing 12
Natera Raises US$54.6 Million In Venture Financing 14
Gene Security Network Secures US$20 Million In Series D Financing 16
Partnerships 17
Natera Enters into Agreement with Imperial College London and University of Leicester 17
Natera Enters into Research Agreement with Aarhus University 18
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 19
Diagcor Enters Into Agreement With Natera To Market Panorama NIPT In Hong Kong 20
Natera And Laboratorio Dr. F Echevarne Analisis Enter Into Agreement To Distribute Panorama 21
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 22
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 23
Equity Offering 24
Natera Raises USD180 Million in IPO 24
Natera Inc – Key Competitors 26
Natera Inc – Key Employees 27
Natera Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Strategy And Business Planning 29
Jan 10, 2017: Natera terminates NIPT distribution agreement with Bioreference Labs 29
Financial Announcements 30
Nov 08, 2017: Natera Reports Third Quarter 2017 Financial Results 30
Aug 08, 2017: Natera Reports Second Quarter 2017 Financial Results 32
May 09, 2017: Natera Reports First Quarter 2017 Financial Results 33
Mar 07, 2017: Natera Reports Fourth Quarter and Fiscal Year 2016 Financial Results 35
Nov 09, 2016: Natera Reports Third Quarter 2016 Financial Results 37
Aug 04, 2016: Natera Reports Second Quarter 2016 Financial Results 39
May 10, 2016: Natera Reports First Quarter 2016 Financial Results 41
Mar 08, 2016: Natera Reports Fourth Quarter and Fiscal Year 2015 Financial Results 43
Corporate Communications 45
May 04, 2017: Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors 45
Feb 03, 2017: Natera Announces Appointment of Mike Brophy as New Chief Financial Officer 46
Apr 25, 2016: Natera Announces the Appointment of Kimberly Martin, MD as Senior Global Medical Director, Women’s Health Franchise 47
Legal and Regulatory 48
Jun 30, 2016: Natera Announces that the U.S. Supreme Court Denies Petition to Review ’540 Patent Invalidation 48
Product News 49
Aug 21, 2017: Natera Launches Signatera Personalized Circulating Tumor DNA Technology for Cancer Research 49
Apr 26, 2017: Study in Nature Shows Early Relapse Detection in Lung Cancer Using Natera’s Technology for ctDNA Analysis 50
Dec 14, 2016: Natera Announces Participation In I-SPY 2 TRIAL For Breast Cancer 51
Mar 11, 2016: American Medical Association Grants New CPT Code for Microdeletion Testing 52
Mar 07, 2016: Published Study Demonstrates Natera’s Ability to Identify Heterogeneous Cancer Mutations in Patients with Early-Stage Lung Cancer 53
02/09/2016: Genetica Now Offering PanoramaTM NIPT in Switzerland via Natera’s Constellation Software Platform 54
01/12/2016: Large-Scale Clinical Study Shows Panorama Prenatal Screen to be Highly Accurate in Identifying 22q11.2 Deletion Syndrome in a General Population 55
Other Significant Developments 56
Sep 20, 2017: Natera Selected for Circulating Tumor DNA Study in Bladder Cancer 56
Mar 01, 2017: Natera Announces Launch of Evercord Cord Blood and Tissue Banking Service 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Natera Inc, Medical Equipment, Key Facts, 2016 2
Natera Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Natera Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Natera Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Natera Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Natera Inc, Deals By Market, 2011 to YTD 2017 9
Natera Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Natera Raises USD55.5 Million in Venture Financing 12
Natera Raises US$54.6 Million In Venture Financing 14
Gene Security Network Secures US$20 Million In Series D Financing 16
Natera Enters into Agreement with Imperial College London and University of Leicester 17
Natera Enters into Research Agreement with Aarhus University 18
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 19
Diagcor Enters Into Agreement With Natera To Market Panorama NIPT In Hong Kong 20
Natera And Laboratorio Dr. F Echevarne Analisis Enter Into Agreement To Distribute Panorama 21
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 22
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 23
Natera Raises USD180 Million in IPO 24
Natera Inc, Key Competitors 26
Natera Inc, Key Employees 27
Natera Inc, Subsidiaries 28

★海外企業調査レポート[Natera Inc (NTRA)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amgen Inc (AMGN)-製薬・医療分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • Chemring Ordnance, Inc.:企業の戦略・SWOT・財務情報
    Chemring Ordnance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Chemring Ordnance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Wolverine Power Supply Cooperative Inc:企業の戦略的SWOT分析
    Wolverine Power Supply Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • DiaCarta Inc:企業の製品パイプライン分析2018
    Summary DiaCarta Inc (DiaCarta) is a developer of molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation detection ki …
  • Novacyt SA (ALNOV):企業の財務・戦略的SWOT分析
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • Dayton Superior Corp:企業の戦略的SWOT分析
    Dayton Superior Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Symbiotec Pharmalab Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Symbiotec Pharmalab Ltd (Symbiotec) is a medical laboratory that manufactures active pharmaceutical ingredients. The laboratory develops, produces and markets research-based cortico steroids and steroid-hormone APIs. Its cortico-steroids APIs include clobetasol propionate, betamethasone dipr …
  • Best Doctors Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Best Doctors Inc (Best Doctors), a subsidiary of Teladoc, Inc, is a healthcare service provider that offers medical services. The company provides services such as inter-consultation and critical care inter-consultation services for multi-trauma, spinal cord injuries, traumatic brain injurie …
  • Bankers Petroleum Ltd:企業の戦略的SWOT分析
    Bankers Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hasbro Inc (HAS):企業の財務・戦略的SWOT分析
    Hasbro Inc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Arkle Resources Plc:企業の戦略・SWOT・財務分析
    Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Archer Ltd (ARCHER):企業の財務・戦略的SWOT分析
    Archer Ltd (ARCHER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Centric Health Corp (CHH):企業の財務・戦略的SWOT分析
    Summary Centric Health Corp (CHC) is a healthcare and wellness service provider. The company operates through specialty pharmacy, orthotics, and surgical and medical centres. Its pharmacies provide traditional pharmacy services such as compounding and dispensing medications, and clinical and special …
  • Recipharm AB:企業の戦略的SWOT分析
    Recipharm AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Delta Air Lines Inc:戦略・SWOT・企業財務分析
    Delta Air Lines Inc - Strategy, SWOT and Corporate Finance Report Summary Delta Air Lines Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Novavax Inc (NVAX):製薬・医療:M&Aディール及び事業提携情報
    Summary Novavax Inc (Novavax) is a clinical-stage biotechnology company that focuses on the discovery, development and commercialization of vaccines to prevent a range of infectious diseases. Its product portfolio includes recombinant nanoparticle vaccines and adjuvants. The company develops vaccine …
  • First Abu Dhabi Bank (FAB):企業の財務・戦略的SWOT分析
    First Abu Dhabi Bank (FAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Viridian Group Investments Limited:戦略・SWOT・企業財務分析
    Viridian Group Investments Limited - Strategy, SWOT and Corporate Finance Report Summary Viridian Group Investments Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Nippon Light Metal Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Nippon Light Metal Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Light Metal Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Citizens Electric Corporation:発電所・企業SWOT分析
    Citizens Electric Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆